Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13Neoplasms 12Glioma 12Glioblastoma 11Prostatic Neoplasms 10Colorectal Neoplasms 10Brain Neoplasms 10Pancreatic Neoplasms 9Neoplasm Metastasis 9Melanoma 8Lymphoma, B-Cell 8Lymphoma 8Recurrence 7Multiple Myeloma 7Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Sarcoma 5Carcinoma, Non-Small-Cell Lung 5Skin Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Hepatocellular 4Advanced Solid Tumors 4Solid Tumor 3Pituitary Neoplasms 3Neoplasms, Plasma Cell 3Myelodysplastic Syndromes 3Lymphoma, Follicular 3Lung Neoplasms 3Carcinoma, Transitional Cell 3

Interventions

antitumor A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Cancer of the Oral Cavity × 90 days × Clear all
NCT04278989 2026-03-25

Inhibition of Oral Tumorigenesis by Antitumor B

Medical College of Wisconsin

Phase EARLY_PHASE1 Completed
30 enrolled 9 charts

Squamous Cell Cancer of the Oral Cavity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡